- Home
- BHAT vs BIAF Comparison
BHAT vs BIAF Comparison
Compare BHAT & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- BIAF
- Stock Information
- Founded
- BHAT 2010
- BIAF 2014
- Country
- BHAT China
- BIAF United States
- Employees
- BHAT N/A
- BIAF N/A
- Industry
- BHAT Recreational Games/Products/Toys
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BHAT Consumer Discretionary
- BIAF Health Care
- Exchange
- BHAT Nasdaq
- BIAF Nasdaq
- Market Cap
- BHAT 12.7M
- BIAF 12.2M
- IPO Year
- BHAT 2019
- BIAF 2022
- Fundamental
- Price
- BHAT $1.67
- BIAF $0.28
- Analyst Decision
- BHAT
- BIAF Hold
- Analyst Count
- BHAT 0
- BIAF 1
- Target Price
- BHAT N/A
- BIAF N/A
- AVG Volume (30 Days)
- BHAT 85.4K
- BIAF 1.6M
- Earning Date
- BHAT 04-30-2025
- BIAF 08-18-2025
- Dividend Yield
- BHAT N/A
- BIAF N/A
- EPS Growth
- BHAT N/A
- BIAF N/A
- EPS
- BHAT N/A
- BIAF N/A
- Revenue
- BHAT $18,724,190.00
- BIAF $8,809,228.00
- Revenue This Year
- BHAT N/A
- BIAF N/A
- Revenue Next Year
- BHAT N/A
- BIAF $20.00
- P/E Ratio
- BHAT N/A
- BIAF N/A
- Revenue Growth
- BHAT N/A
- BIAF 78.40
- 52 Week Low
- BHAT $1.61
- BIAF $0.16
- 52 Week High
- BHAT $72.80
- BIAF $2.26
- Technical
- Relative Strength Index (RSI)
- BHAT 38.80
- BIAF 41.91
- Support Level
- BHAT $1.75
- BIAF $0.27
- Resistance Level
- BHAT $1.79
- BIAF $0.30
- Average True Range (ATR)
- BHAT 0.09
- BIAF 0.02
- MACD
- BHAT -0.01
- BIAF -0.01
- Stochastic Oscillator
- BHAT 9.27
- BIAF 9.68
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.